Regarding the underlying mechanism of cancer cell–mediated CCL2 secretion, Li et al. demonstrated that genetic inactivation of retinoblastoma increases the secretion of CCL2 by sarcoma and breast cancer cells by activating the JNK signaling pathway [29]. This evidence concerns the gene MAPK8 and breast carcinoma.